< Back to latest news & events

Event

Challenging granted patents: a comparison between Europe and the US

October 2021

Event date: 3rd November 2021

HGF and Knobbe Martens are holding a webinar on 3rd November.

Challenging granted patents: a comparison between Europe and the US

In this webinar we will compare and contrast mechanisms for challenging patents in both Europe and the US. In particular, we will focus on opposition proceedings before the European Patent Office (EPO) along with proceedings at the Patent Trial and Appeal Board (PTAB) in the US. Comparisons will be made between each of the jurisdictions illustrated by case studies as examples. Additionally, the panel will provide practical tips on how to maximize the chance of success in each jurisdiction.

This webinar will cover:

  • An outline of the European opposition process and PTAB trials process in the US generally, including inter partes review (IPR) and post-grant review (PGR)
  • Tactical considerations and approach prior to filing an opposition in Europe or a petition for IPR/PGR in the US
  • Discussion of key differences between European and the US invalidity proceedings
  • Practice updates from Europe, including the use of videoconferencing for oral proceedings and changes to the Rules of Procedure at the Boards of Appeal
  • Practice updates from the US, including discretionary denials and the many challenges to the NHK-Fintiv rule, which may block IPRs when co-pending litigation exists
  • Strategy considerations in deciding whether to challenge a U.S. patent versus a European patent.
Speakers

Attendees

Latest updates

PRESS RELEASE - HGF Appoints new Chair of the Board: Formerly Head of Engineering, Lucy Johnson

HGF announced a new Chair to its Management Board, Lucy Johnson. Lucy was previously head of the firm’s Engineering Group.  Effective immediately Lucy succeeds Jason Lumber who held the position …

Read article

Celebrating Success in the Pharmaceuticals Industry: Jazz Pharmaceuticals Enters Deal With Redx

HGF would like to congratulate Redx Pharmaceuticals on their recent deal with Jazz Pharmaceuticals concerning the global rights to Redx’s KRAS Inhibitor Program. This partnership has the potential to provide …

Read article

What's Next for CAR Cell Therapy?

The first generation CAR T cell was discovered in 1993 when the variable region of an antibody was fused to the constant regions of a T cell receptor.  Now, 20 …

Read article

Blog Series: IP Ingredients, Part 7: Data in food and beverage parent applications - Why, What & How much?

Questions I often get asked by innovators looking to file a patent application include: “What kind of experimental data do I need to include?” and “How many examples do we …

Read article

HGF ranked in The Legal 500 Germany 2024

HGF is proud to be ranked in The Legal 500 Germany 2024 guide. The Legal 500 provides the most comprehensive worldwide coverage on recommended Law firms, Lawyers, Attorneys, Advocates, Solicitors, …

Read article

EPO Annual Fee Increases

The European Patent Office (EPO) has announced that revised Official Fees will apply to payments made on or after Monday 1st April 2024. The majority of fees will increase by …

Read article

Tanya Waller Recognised as Lexology Legal Influencer for IP

We are delighted to share that our Trade Mark Director Tanya Waller has been recognised as a Lexology Legal influencer for Q4/2023! Tanya provides high-quality legal content for our website …

Read article